Could First Solar Be a Millionaire-Maker Stock?
It's a great company, but is it a great stock?
Editors' Picks
Here's Why Zoom Stock Has Been Soaring -- and What to Expect Going Forward
Following a more than doubling of its stock over the last six months, expectations are high going into the videoconferencing company's earnings report next week.
JPMorgan on Pace for Another Strong Quarter of Trading Revenue
The bank's investment banking head said trading revenue in Q2 could be 50% higher on a year-over-year basis.
Hertz Burns Carl Icahn in Bankruptcy
Even the best investors can make a bad move. Here's how much Carl Icahn lost on Hertz.
Recent articles
Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical Trials
The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease.
Is Lululemon About to Shoot 12% Higher?
The stock has been on fire lately, and a noted analyst thinks it'll only get hotter.
Why Tilray and OrganiGram Holdings Got Slammed on Friday
They can blame a high-profile peer in their sector.
Five Below Still Plans to Open Over 100 Stores This Year
The new target is a modest downgrade from the retailer's prior expansion goal.
Why Moderna Stock Jumped 10.7% Today
The biotech is beginning a new study for its experimental COVID-19 vaccine.
Why Tech Stocks DocuSign, CrowdStrike, and Zoom Video All Closed Higher on Friday
Next week is a big week for tech earnings.
Stock Market Wrap-Up: Yes, This Retail Stock Really Did Hit a Record High Friday
The overall market was mixed to finish the week, but even a hard-hit industry had a big winner.
Why Zscaler Stock Surged Today
Tens of millions more Americans are working from home amid the COVID-19 pandemic, and that's fueling torrid growth for the cloud security leader.
Avid Technology Stock Rises After an Activist Investor Ups Its Stake
Investors were inspired by Impactive Capital's vote of confidence.
Here's Why Minerva Neurosciences Collapsed Today
The company's lead drug candidate flopped in a phase 3 trial. Can a longer-term follow-up study resurrect the asset?
Dynavax Stock Soars 26.4% Today on COVID-19 Vaccine Hopes
The company's vaccine partner made positive comments about its progress today.
Why Coty Stock Was Falling Today
Shares of the company fell on a report that showed it may have overpaid for Kylie Cosmetics.
Sony PlayStation 5 Will Have Games Exclusive to the Device
Sony has long subscribed to the belief that each new console generation should have games that take advantage of the new technology's enhancements.
NetEase Officially Applies for Secondary Listing in Hong Kong
NetEase didn't disclose how much it's seeking to raise and the timing for the listing.
Google Cancels Job Offers to More Than 2,000 Workers
Staffing firms may also take a revenue hit.
Uber Rolls Out Rides By the Hour in the U.S
Uber riders can keep the same driver for an hour to run errands or take a family member to the doctor.
Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today
The development-stage biopharma is bouncing back from a recent stock dip.
Why DXC Technology Stock Tumbled Today
Revenue was down more than expected, and the dividend is no more.
Why Cognex Stock Plunged Today
The machine-vision specialist is laying off workers in an effort to cut costs as COVID-19 hits the company's end markets.
Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today
Positive results from a handful of patients treated have bolstered confidence in the company's cell-based approach to cancer treatment.